eSTI2 consortium (@eSTI2_org) profile picture
Joined November 2010
Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)Photo by eSTI2 consortium (@eSTI2_org)
Claire Elizabeth Broad wins best oral presentation at the World HIV/STI Congress at Rio. Coinfection of Mycoplasma genitalium and other STIs
1
2
5
#stihiv17 Dr Harding Esch: Cost effectiveness of AMR POCT strategies for optimising NG treatment @SGUL_III
2
1
Six alternative strategies for POC AMR testing in gonorrhoea explained by Dr Harding-Esch from St George's, University of London
1
1
Dr Emma Harding Esch presenting on Cost effectiveness of AMR Point of Care testing at World STI and HIV Congress in Rio de Janeiro
2
2
#stirio17 Claire Broad: most co-infection is CT-MG, high MG #AMR. MG not routinely tested for, fuelling resistance. MG mainly rectal in MSM
2
3
#stirio17 Janssen: comparable proportion of female anorectal/genital samples within highest CT viability category
#stirio17 Claire Broad @SGUL_III @PreciseResUK presenting on MG co-infection & #AMR, 2.10pm El Pardo I
#stirio17 Emma Cousins @SGUL_III presenting @Atlas_Genetics #chlamydia #POCT results in Segovia IV, 2.10pm
#stirio17 - concluding slide by Catriona Bradshaw on Mycoplasma genitalium #AMR
#stirio17 Magnus Unemo conclusions from talk on #gonorrhoea #AMR
2
With @AquariusPH @Atlas_Genetics @SGUL_III @innovateuk : CT-NG-TV-MG #POCT has most benefits compared with Standard Care xitter.gq/eSTI2_org/status/88453…
#stirio17 Dr Harding-Esch 'Evaluating costs, benefits and cost effectiveness of multi pathogen POCTs for STIs' poster table 8!
2
1
#stirio17 Dr Harding-Esch 'Evaluating costs, benefits and cost effectiveness of multi pathogen POCTs for STIs' poster table 8!
#stirio17 @PreciseResUK @seb_fuller - "it's not a 'time spent' issue, it's a 'what have you spent your time doing?' issue". Poster,table 30!
2
2
#stirio17 @mpondie poster: oligotype populations are different in urethritis & non-urethritis/asymptomatic men
2
2
#stirio17 Laura Phillips poster 1.32 (monitor 7): handheld whole genome sequencing for gonorrhoea antibiotic susceptibility
1
3
#stirio17 @nicolamlow - as an #STI community we're very good at talking to each other but not to the policy makers
1
2
#stirio17 @TheLancetInfDis - current and future gonorrhoea treatment & control options
#stirio17 @TheLancetInfDis - some strategies for Chlamydia control
1
1
#stirio17 @PreciseResUK @SGUL_III - qualitative interviews & public advisory group: complementary & different insight for test development
1
1